Literature DB >> 8533906

Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury.

A Benzing1, P Bräutigam, K Geiger, T Loop, U Beyer, E Moser.   

Abstract

BACKGROUND: In acute lung injury, when pulmonary microvascular permeability is enhanced, transvascular fluid filtration mainly depends on pulmonary capillary pressure. Inhaled nitric oxide has been shown to decrease pulmonary capillary pressure. Therefore, the effect of inhaled nitric oxide at a concentration of 40 ppm on pulmonary transvascular albumin flux was studied in nine patients with acute lung injury.
METHODS: Transvascular albumin flux was measured by a double radioisotope method using 99mTc-labeled albumin and 51Cr-labeled autologous red blood cells. Radioactivity of both isotopes was externally measured over the right lung by a gamma scanner and simultaneously in arterial blood. The normalized ratio of 99mTc/51Cr lung to 99mTc/51Cr blood (normalized index) was calculated. The normalized slope index which is the slope of the regression line of the normalized index versus time represents the accumulation rate of albumin in the interstitial space of the lungs. Normalized slope index and pulmonary capillary pressure were determined before, during, and after inhalation of 40 ppm nitric oxide. Pulmonary capillary pressure was estimated using the visual analysis of the pressure decay curve after pulmonary artery occlusion.
RESULTS: Normalized slope index decreased from 0.0077 +/- 0.0054 min-1 (SD) off nitric oxide to -0.0055 +/- 0.0049 min-1 (P < 0.01) during nitric oxide and increased to 0.0041 +/- 0.0135 min-1 after nitric oxide. Pulmonary capillary pressure declined from 24 +/- 4 mmHg off nitric oxide to 21 +/- 4 mmHg during nitric oxide (P < 0.01), whereas pulmonary artery wedge pressure and cardiac output did not change.
CONCLUSIONS: It is concluded that 40 ppm inhaled nitric oxide decreases pulmonary transvascular albumin flux in patients with acute lung injury. This effect may be the result of the decrease in pulmonary capillary pressure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533906     DOI: 10.1097/00000542-199512000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  11 in total

1.  Pulmonary capillary pressure.

Authors:  Jukka Takala
Journal:  Intensive Care Med       Date:  2003-05-08       Impact factor: 17.440

2.  Inhaled nitric oxide for ARDS: searching for a more focused use.

Authors:  Luca M Bigatello; Judith Hellman
Journal:  Intensive Care Med       Date:  2003-10       Impact factor: 17.440

3.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

Review 4.  Inhaled nitric oxide in neonates.

Authors:  N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

5.  Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Authors:  Michael Hawkes; Robert Opika Opoka; Sophie Namasopo; Christopher Miller; Andrea L Conroy; Lena Serghides; Hani Kim; Nisha Thampi; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Med Hypotheses       Date:  2011-07-13       Impact factor: 1.538

6.  Preventive influence of inhaled nitric oxide on lung ischemia-reperfusion injury.

Authors:  H Yamagishi; C Yamashita; M Okada
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

7.  Estimation of pulmonary capillary pressure: different methods for different pathophysiological processes?

Authors:  Silvia Nunes
Journal:  Crit Care       Date:  2005-02-17       Impact factor: 9.097

8.  Nitric oxide, leukocytes and microvascular permeability: causality or bystanders?

Authors:  Balázs Hauser; Martin Matejovic; Peter Radermacher
Journal:  Crit Care       Date:  2008-01-16       Impact factor: 9.097

9.  Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease.

Authors:  Ayako Chida-Nagai; Koichi Sagawa; Takao Tsujioka; Takanori Fujimoto; Kota Taniguchi; Osamu Sasaki; Gaku Izumi; Hirokuni Yamazawa; Naoki Masaki; Atsushi Manabe; Atsuhito Takeda
Journal:  Heart Vessels       Date:  2020-04-13       Impact factor: 2.037

Review 10.  Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives.

Authors:  Holger C Müller-Redetzky; Norbert Suttorp; Martin Witzenrath
Journal:  Cell Tissue Res       Date:  2014-03-06       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.